Investigation of various shellac grades: Additional analysis for identity

Drug Development and Industrial Pharmacy

Volumn 35, Issue 6, 2009, Pages 694-703

  Buch, Karl ^a   Penning, Manfred ^b   Wchtersbach, Eva ^a   Maskos, Michael ^a   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Pennconsult   (Germany)

Author keywords

Shellac

Indexed keywords

SHELLAC;

ARTICLE; CHEMICAL STRUCTURE; COLOR; DRUG COATING; DRUG PURITY; DRUG QUALITY; GLASS TRANSITION TEMPERATURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHYSICAL CHEMISTRY; PKA;

ANIMALS; COLOR; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; INSECTS; QUALITY CONTROL; RESINS, PLANT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSITION TEMPERATURE;

EID: 70350610906     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802563253     Document Type: Article

References (15)

1. Pearnchob N, Dashevsky A, Siepmann J, Bodmeier R. (2003). Shellac used as coating material for solid pharmaceutical dosage forms: Understanding the effects of formulation and processing variables. STP Pharm Sci, 13(6):387-396
2. Pearnchob N, Siepmann J, Bodmeier R. (2003). Pharmaceutical applications of shellac: Moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug Dev Ind Pharm, 29(8):925-938
3. Mukhopadhyay B, Muthana MS. (1962). A Monograph on lac. Howrah: Glasgow Printing Company Private. Ltd.
4. Penning M. (1990). Schellack - ein nachwachsender Rohstoff mit interessanten Eigenschaften und Anwendungen. Seifen - Öle - Fette - Wachse, 1990(6):221-224
5. Penning M. (1996). Aqueous shellac solutions for controlled release coatings. In: Karsa DR, Stephenson RA, eds. Chemical aspects of drug delivery systems. Royal Society of Chemistry, 178:146-154
6. Angelo Brothers Limited. (1965). Shellac. Calcutta, India: Cossipore.
7. Parke TV, Davis WW. (1954). Use of apparent dissociation constants in qualitative organic analysis. Anal Chem, 26(4):642-645
8. Riedel A. (2005). Interaktionen zwischen Kernbestandteilen und Filmüberzügen und ihre Auswirkung auf die Wirkstofffreisetzung aus magensaftresistent überzogenen Arzneiformen. Berlin: Logos-Verlag.
9. Tang, J. (2003). Characterization of Shellac by MALDI-TOF-MS, ESI-TOF-MS and MS-MS. Poster MPP 301, 51st ASMS Meeting, Montreal.
10. Marx EL. (1964). Die wichtigsten Kennzahlen von Schellack und deren Bestimmung. Deutsche Farben-Zeitschrift, 18(8):347-351
11. Specht F. (1998). The Application of shellac as an acidic polymer for enteric coating. Pharm Technol Eur, 10:20-28
12. Luce GT. (1978). Disintegration of tablets enteric coated with CAP (cellulose acetate phthalate). Manuf Chem Aerosol News, 49(50):50.
13. Signorino C. (2003). United States Patent No. 6620431.
14. Chambliss WG. (1983). The forgotten dosage form: Enteric coated tablets. Pharm Technol, 7(9):124-140
15. Wang L, Ishida Y, Ohtani H, Tsuge S, Nakayama T. (1999). Characterization of natural resin shellac by reactive pyrolysisgas chromatography in the presence of organic alkali. Anal Chem, 71(7):1316-1322